pBEL1200
(Plasmid
#138526)
-
PurposeFor expresson of mlaFEDCB operon from E. coli. N-terminal his tag on MlaD, araBAD promoter.
-
Depositing Labs
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 138526 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepBAD-His
-
Backbone manufacturerThermo Fisher
- Backbone size w/o insert (bp) 4571
- Total vector size (bp) 7728
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namemlaFEDCB
-
SpeciesE. coli
-
Insert Size (bp)3157
-
Entrez GenemlaF (a.k.a. b3195, ECK3184, vpsA(S.f.), yrbF)
-
Entrez GenemlaE (a.k.a. b3194, ECK3183, vpsB(S.f.), yrbE)
-
Entrez GenemlaD (a.k.a. b3193, ECK3182, vpsC(S.f.), yrbD)
-
Entrez GenemlaC (a.k.a. b3192, ECK3181, yrbC)
-
Entrez GenemlaB (a.k.a. b3191, ECK3180, yrbB)
- Promoter araBAD
-
Tag
/ Fusion Protein
- N-terminal His tag and TEV cleavage site on MlaD (N terminal on insert)
Cloning Information
- Cloning method Gibson Cloning
- 5′ sequencing primer pBAD fwd
- 3′ sequencing primer pBAD rev (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pBEL1200 was a gift from Gira Bhabha & Damian Ekiert (Addgene plasmid # 138526 ; http://n2t.net/addgene:138526 ; RRID:Addgene_138526) -
For your References section:
Architectures of Lipid Transport Systems for the Bacterial Outer Membrane. Ekiert DC, Bhabha G, Isom GL, Greenan G, Ovchinnikov S, Henderson IR, Cox JS, Vale RD. Cell. 2017 Apr 6;169(2):273-285.e17. doi: 10.1016/j.cell.2017.03.019. 10.1016/j.cell.2017.03.019 PubMed 28388411